Elite Trades From Anywhere

$100 Off Your First Year

00
Days
00
Hours
00
Mins
00
Sec
Claim Now
Index
RUT
Market Cap
1.39B
Enterprise Value
3.16B
Income
-495.80M
Sales
1.64B
Book/sh
13.40
Cash/sh
3.41
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
4427
IPO
Aug 16, 1995
P/E
-
Forward P/E
6.83
PEG
0.79
P/S
0.85
P/B
1.33
P/C
5.24
P/FCF
340.93
EV/EBITDA
9.88
EV/Sales
1.92
Quick Ratio
1.95
Current Ratio
3.38
Debt/Eq
1.96
LT Debt/Eq
1.91
Option/Short
Yes / Yes
EPS (ttm)
-6.46
EPS next Y
2.62
EPS next Q
0.48
EPS this Y
9.89%
EPS next Y
6.86%
EPS next 5Y
8.68%
EPS past 3/5Y
- -
Sales past 3/5Y
1.63% 3.57%
EPS Y/Y TTM
-1605.54%
Sales Y/Y TTM
1.24%
EPS Q/Q
81.86%
Sales Q/Q
2.42%
Insider Own
14.44%
Insider Trans
0.00%
Inst Own
97.06%
Inst Trans
0.51%
ROA
-13.00%
ROE
-38.64%
ROIC
-16.37%
Gross Margin
55.12%
Oper. Margin
10.19%
Profit Margin
-30.15%
SMA20
0.99%
SMA50
17.67%
SMA200
38.65%
Trades
Shs Outstand
77.82M
Shs Float
66.56M
52W High
18.92 -5.50%
52W Low
8.70 105.52%
Volatility
4.11% 4.55%
ATR (14)
0.77
RSI (14)
59.83
Beta
1.21
Rel Volume
0.43
Avg Volume
1.00M
Volume
420,640
Perf Week
-1.22%
Perf Month
14.10%
Perf Quarter
86.83%
Perf Half Y
41.01%
Perf YTD
43.96%
Perf Year
32.25%
Perf 3Y
-56.53%
Perf 5Y
-74.42%
Perf 10Y
-55.38%
Prev Close
17.89
Price
17.88
Change
-0.06%
Date Action Analyst Rating Change Price Target Change
Jun-18-26Upgrade Argus Hold → Buy $25
May-28-26Upgrade Citigroup Sell → Neutral $16
Apr-15-26Downgrade Argus Buy → Hold
Mar-31-25Upgrade Argus Hold → Buy
Dec-02-24Initiated Morgan Stanley Underweight $25 → $20
Oct-07-24Upgrade BTIG Research Sell → Neutral
Jul-30-24Downgrade Citigroup Neutral → Sell $30 → $23
Jul-30-24Downgrade BTIG Research Neutral → Sell $22
May-07-24Downgrade Wells Fargo Overweight → Equal Weight $45 → $25
May-07-24Downgrade Oppenheimer Outperform → Perform
Today 08:30AM
Jun-23-26 08:00AM
Jun-15-26 08:30AM
Jun-02-26 09:00AM
07:30AM
10:31AM Loading…
May-22-26 10:31AM
May-08-26 08:00AM
May-05-26 04:54PM
06:15AM
06:00AM
06:00AM
Apr-20-26 08:32AM
Apr-15-26 09:47AM
Apr-07-26 08:30AM
Mar-11-26 05:25AM
02:00PM Loading…
Mar-06-26 02:00PM
Mar-02-26 07:41AM
Feb-27-26 09:50AM
Feb-26-26 05:03PM
04:09PM
03:01PM
09:30AM
08:15AM
06:36AM
06:32AM
06:00AM
Feb-25-26 06:10AM
Feb-23-26 12:00PM
Feb-19-26 11:34PM
Feb-17-26 08:30AM
06:35AM Loading…
Feb-09-26 06:35AM
Jan-23-26 12:22PM
Jan-16-26 09:27AM
Jan-05-26 04:31PM
Jan-04-26 11:02PM
Dec-05-25 11:30AM
Dec-01-25 04:30PM
Nov-25-25 08:30AM
Nov-24-25 01:00PM
Nov-16-25 10:31PM
Nov-13-25 03:05PM
Nov-11-25 04:15PM
Nov-06-25 12:38AM
Nov-03-25 04:00PM
Oct-31-25 10:20AM
Oct-30-25 04:31PM
01:16PM
09:30AM
07:10AM
06:09AM
06:07AM
06:00AM
Oct-29-25 09:48AM
Oct-28-25 11:11PM
Oct-15-25 02:01PM
08:30AM
Oct-10-25 03:50PM
Oct-08-25 08:30AM
Sep-30-25 12:03AM
Sep-25-25 01:06PM
Sep-22-25 08:30AM
Sep-16-25 10:38AM
Sep-08-25 02:25PM
Aug-29-25 04:30PM
05:06AM
Aug-27-25 11:31PM
Aug-22-25 12:32AM
Aug-21-25 02:55PM
Aug-13-25 12:25AM
12:06AM
Aug-11-25 04:06PM
Jul-31-25 09:30AM
07:10AM
06:28AM
06:06AM
06:00AM
Jul-30-25 09:52AM
Jul-29-25 11:09PM
Jul-14-25 04:35PM
Jul-03-25 09:23AM
Jul-02-25 04:09PM
Jun-26-25 05:47PM
Jun-06-25 11:31AM
Jun-04-25 11:30AM
Jun-03-25 11:37PM
May-30-25 08:32AM
May-28-25 12:01AM
May-06-25 09:04AM
03:03AM
02:14AM
May-05-25 01:54PM
09:30AM
07:40AM
06:39AM
06:30AM
May-02-25 09:25AM
Apr-29-25 09:02AM
Apr-25-25 09:13AM
Apr-18-25 04:30PM
Apr-09-25 08:42AM
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
CEODr. Stuart M. Essig Ph.D.
Executive VP & CFOMs. Lea Daniels Knight
Executive VP & President of International BusinessMr. Harvinder Pal Singh
Senior VP of Finance & Principal Accounting OfficerMr. Jeffrey A. Mosebrook
Corporate VP & Chief Technology OfficerMr. Teshtar Elavia
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 11 '26Option Exercise0.0018,922040,612Mar 12 06:10 PM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 10 '26Option Exercise0.001,216023,152Mar 12 06:10 PM
Poul MojdehPresident & CEOJan 06 '26Option Exercise0.001,39001,390Jan 07 04:10 PM
GRAVES JEFFREY ADirectorNov 05 '25Buy11.359,000102,15041,086Nov 06 04:05 PM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALOct 12 '25Option Exercise0.0011,965025,217Oct 14 04:28 PM